Global Transdermal Drug Delivery System Market Survey and Trend Research 2018

January 2018 | 105 pages | ID: G7FE4111982EN
99Strategy

Abstracts

Summary

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Hisamitsu, Mylan, GSK, Novartis, Johnson & Johnson, Johnson & Johnson, Lohmann, Teikoku Seiyaku, Bayer, Lingrui, Sanofi, Qizheng, Endo, Huarun 999, Haw Par, Nichiban, Mentholatum Company, Laboratoires Genevrier etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Transdermal Drug Delivery System Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 TRANSDERMAL DRUG DELIVERY SYSTEM MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Hisamitsu (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Mylan (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 GSK (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Novartis (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Johnson & Johnson (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Johnson & Johnson (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Lohmann (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Teikoku Seiyaku (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Bayer (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Lingrui (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Sanofi (Company Overview, Sales Data etc.)
4.12 Qizheng (Company Overview, Sales Data etc.)
4.13 Endo (Company Overview, Sales Data etc.)
4.14 Huarun 999 (Company Overview, Sales Data etc.)
4.15 Haw Par (Company Overview, Sales Data etc.)
4.16 Nichiban (Company Overview, Sales Data etc.)
4.17 Mentholatum Company (Company Overview, Sales Data etc.)
4.18 Laboratoires Genevrier (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET 2012-2017, BY TYPE, IN USD MILLION
Table Global Transdermal Drug Delivery System Market 2012-2017, by Type, in Volume
Table Global Transdermal Drug Delivery System Market Forecast 2018-2023, by Type, in USD Million
Table Global Transdermal Drug Delivery System Market Forecast 2018-2023, by Type, in Volume
Table Hisamitsu Overview List
Table Transdermal Drug Delivery System Business Operation of Hisamitsu (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan Overview List
Table Transdermal Drug Delivery System Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GSK Overview List
Table Transdermal Drug Delivery System Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Transdermal Drug Delivery System Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Transdermal Drug Delivery System Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Transdermal Drug Delivery System Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Lohmann Overview List
Table Transdermal Drug Delivery System Business Operation of Lohmann (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teikoku Seiyaku Overview List
Table Transdermal Drug Delivery System Business Operation of Teikoku Seiyaku (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer Overview List
Table Transdermal Drug Delivery System Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Lingrui Overview List
Table Transdermal Drug Delivery System Business Operation of Lingrui (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Transdermal Drug Delivery System Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Qizheng Overview List
Table Transdermal Drug Delivery System Business Operation of Qizheng (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Endo Overview List
Table Transdermal Drug Delivery System Business Operation of Endo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Huarun 999 Overview List
Table Transdermal Drug Delivery System Business Operation of Huarun 999 (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Haw Par Overview List
Table Transdermal Drug Delivery System Business Operation of Haw Par (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Nichiban Overview List
Table Transdermal Drug Delivery System Business Operation of Nichiban (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mentholatum Company Overview List
Table Transdermal Drug Delivery System Business Operation of Mentholatum Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Laboratoires Genevrier Overview List
Table Transdermal Drug Delivery System Business Operation of Laboratoires Genevrier (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Transdermal Drug Delivery System Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Transdermal Drug Delivery System Sales Revenue Share, by Companies, in USD Million
Table Global Transdermal Drug Delivery System Sales Volume 2012-2017, by Companies, in Volume
Table Global Transdermal Drug Delivery System Sales Revenue Share, by Companies in 2017, in Volume
Table Transdermal Drug Delivery System Demand 2012-2017, by Application, in USD Million
Table Transdermal Drug Delivery System Demand 2012-2017, by Application, in Volume
Table Transdermal Drug Delivery System Demand Forecast 2018-2023, by Application, in USD Million
Table Transdermal Drug Delivery System Demand Forecast 2018-2023, by Application, in Volume
Table Global Transdermal Drug Delivery System Market 2012-2017, by Region, in USD Million
Table Global Transdermal Drug Delivery System Market 2012-2017, by Region, in Volume
Table Transdermal Drug Delivery System Market Forecast 2018-2023, by Region, in USD Million
Table Transdermal Drug Delivery System Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Transdermal Drug Delivery System Industry Chain Structure
Figure Global Transdermal Drug Delivery System Market Growth 2012-2017, by Type, in USD Million
Figure Global Transdermal Drug Delivery System Market Growth 2012-2017, by Type, in Volume
Figure Global Transdermal Drug Delivery System Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Transdermal Drug Delivery System Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region